Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

The Carroll County Community Foundation is pleased to announce the recipient of the 2025 Lilly Endowment Community ...

A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease, a new ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest pharma market. The National Medical ...

georgina sex Blockbuster psoriasis drugs were quickly approved, Eli Lilly, Novartis, and Johnson & Johnson staged a "Three Kingdoms" After spending tens of billions of dollars, AI doctor still failed!

wingo tool Eli Lilly's "cancer-free" RET inhibitor clinical data officially published in NEJM Well-known pharmaceutical companies respond to investigation of medical representatives Merck's SGLT-2 ...

full name of ipl teams The National Health Commission announced 12 major medical reform plans InnoCare Pharma's Hong Kong Stock Exchange "Cloud Ringing" Ceremony, Shi Yigong's Support Has Received ...

Younger Dryas impact theory explained Significant pain relief! Eli Lilly's REYVOW Phase 2 clinical results for the treatment of mi ...